Key result
Pneumonectomy and FEV1 ≤70% linked to higher 30-day adverse outcomes, including ~6% post-pneumonectomy mortality.
Why the study?
What are the risk factors for adverse outcomes in patients undergoing lung cancer surgery?
Population
616 patients referred for surgery for primary lung cancer (394 men, 222 women)
Design
Cohort
Follow-up
30 days
Authors
Loading...
May inform perioperative risk assessment in lung cancer surgery; leaves open impact on patient selection pending prospective data.
Cohort (n=616)
What are the risk factors for adverse outcomes in patients undergoing lung cancer surgery?
Absolute Event Rate: 5.7% vs 0.6%
Pneumonectomy and reduced lung capacity (FEV1 ≤70%) are independent predictors of adverse outcomes within 30 days after lung cancer surgery.
Gunnar Mýrdal (2001) conducted a cohort in primary lung cancer (n=616). Pneumonectomy vs. Single lobectomy was evaluated on 30-day mortality. Pneumonectomy and FEV1 ≤70% were independent predictors of adverse outcomes within 30 days of lung cancer surgery, with 30-day mortality of 5.7% after pneumonectomy vs 0.6% after single lobectomy.